Chemtura (CHMT) Misses Q2 EPS by 4c

Chemtura (NYSE: CHMT) reported Q2 EPS of $0.32, $0.04 worse than the analyst estimate of $0.36. Revenue for the quarter came in at $609 million versus the consensus estimate of $623.6 million.

For earnings history and earnings-related data on Chemtura (CHMT) click here.

You May Also Be Interested In

• Okta upgraded as AI security opportunity boosts outlook
• Citi raises Huya price target to $4.60 from $4.40
• Bernstein SocGen on Intuitive Surgical (ISRG): 'We see $400 as a great entry point'